Digital health technologies for myopia care: a systematic review
- 1Eye School, Chengdu University of Traditional Chinese Medicine
- 2Sichuan Provincial Key Laboratory of Traditional Chinese Medicine for Ophthalmic Health
- 3Retinal Image Technology and Chronic Vascular Disease Prevention & Control and Collaborative Innovation Center
Abstract
Purpose: Review the application and efficacy of digital health technologies (DHTs) in myopia care.
Methods: This systematic review is registered on PROSPERO (CRD42024626798). Using appropriate medical subject headings and keywords, the authors searched multiple databases (PubMed, Embase, Cochrane, China National Knowledge Infrastructure, Wanfang data and VIP Database) to identify relevant studies published between 1 January 2000 and 1 December 2025. After duplicate removal, the titles and abstracts were screened, followed by full-text eligibility assessment and quality evaluation. Risk of bias was assessed by the Study Quality Assessment Tools. The quality of evidence was graded using the GRADEpro system.
Results: Thirty-three articles with 26,651 patients were finally included in this review. This review included 5 cohort studies, 1 cross-over study, 15 cross-sectional studies, 2 non-RCTs, 5 RCTs, and 5 self-controlled studies. These 33 studies managed myopia by visual and refractive monitoring ( n = 10), environmental and behavioral assessment ( n = 7), visual and refractive improvement ( n = 7), disease diagnosis ( n = 6) and behavioral interventions ( n = 3).
Conclusion: Preliminary evidence suggests that DHTs may have potential values in myopic detection, treatment and management. However, the current evidence base is limited by small sample sizes, high heterogeneity, and very low certainty across all domains. Well-designed RCTs are needed to confirm their effectiveness. Given the predominance of evidence from East Asia, applicability to other regions remains uncertain.
Related
- Digital health technologies and measurable management outcomes in primary care: A systematic review, descriptive quantitative synthesis, and temporal sensitivity analysis
- Assessment and implementation of AI-enabled digital health technologies in hospitals: a review and qualitative document analysis of HTA reports and guidance documents.
- Comparative efficacy of different digital technologies in adults with insomnia: a systematic review and network meta-analysis of randomized controlled trials
- Comparative efficacy of digital health intervention delivery modalities on quality of life, anxiety, and depression in coronary heart disease: a systematic review and network meta-analysis
- Digital Health Information Systems and Patient-Centered NCD Promotion: A Systematic Review
BibTeX
@article{xu2026digital,
title = {{Digital health technologies for myopia care: a systematic review}},
author = {Haofei Xu and Liuqing He and Zhou Pan and Xuejing Lu},
journal = {Frontiers in Public Health},
year = {2026},
month = oct,
doi = {10.3389/fpubh.2026.1939923},
url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1939923/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Digital health technologies for myopia care: a systematic review
AU - Haofei Xu
AU - Liuqing He
AU - Zhou Pan
AU - Xuejing Lu
PY - 2026
DA - 2026/10/16
JO - Frontiers in Public Health
DO - 10.3389/fpubh.2026.1939923
UR - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1939923/full
AB - Purpose: Review the application and efficacy of digital health technologies (DHTs) in myopia care. Methods: This systematic review is registered on PROSPERO (CRD42024626798). Using appropriate medical subject headings and keywords, the authors searched multiple databases (PubMed, Embase, Cochrane, China National Knowledge Infrastructure, Wanfang data and VIP Database) to identify relevant studies published between 1 January 2000 and 1 December 2025. After duplicate removal, the titles and abstracts were screened, followed by full-text eligibility assessment and quality evaluation. Risk of bias was assessed by the Study Quality Assessment Tools. The quality of evidence was graded using the GRADEpro system. Results: Thirty-three articles with 26,651 patients were finally included in this review. This review included 5 cohort studies, 1 cross-over study, 15 cross-sectional studies, 2 non-RCTs, 5 RCTs, and 5 self-controlled studies. These 33 studies managed myopia by visual and refractive monitoring ( n = 10), environmental and behavioral assessment ( n = 7), visual and refractive improvement ( n = 7), disease diagnosis ( n = 6) and behavioral interventions ( n = 3). Conclusion: Preliminary evidence suggests that DHTs may have potential values in myopic detection, treatment and management. However, the current evidence base is limited by small sample sizes, high heterogeneity, and very low certainty across all domains. Well-designed RCTs are needed to confirm their effectiveness. Given the predominance of evidence from East Asia, applicability to other regions remains uncertain.
SN - 2296-2565
ER -